WOODMONT INVESTMENT COUNSEL LLC - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 41 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOODMONT INVESTMENT COUNSEL LLC ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2016$10,000
+11.1%
2,0000.0%0.00%0.0%
Q1 2016$9,000
-18.2%
2,0000.0%0.00%0.0%
Q4 2015$11,000
-8.3%
2,0000.0%0.00%
-25.0%
Q3 2015$12,000
-57.1%
2,000
-50.0%
0.00%0.0%
Q2 2015$28,000
-45.1%
4,000
-60.0%
0.00%
-76.5%
Q2 2013$51,00010,0000.02%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2016
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 78,625$414,0000.24%
THOMPSON DAVIS & CO., INC. 16,650$88,0000.12%
Ariel Investments 1,416,660$7,452,0000.09%
Stanley-Laman Group, Ltd. 80,335$423,0000.07%
Spark Investment Management LLC 50,900$267,0000.03%
JW Asset Management, LLC 10,939$58,0000.02%
PDT Partners, LLC 25,634$135,0000.02%
EAGLE GLOBAL ADVISORS LLC 76,896$404,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 127,300$670,0000.01%
DELTA ASSET MANAGEMENT LLC/TN 12,000$63,0000.01%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders